Robinson John Edward
Chief Scientific Officer
Robinson John Edward has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Dec 30, 2025.
On the most recent filing, Robinson John Edward is listed as Chief Scientific Officer at Cogent Biosciences, Inc. Inside the rolling window, Robinson John Edward reported no open-market purchases and 1 open-market sale totaling $3.5M in COGT.
Companies traded
Other insiders at COGT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Robinson John Edward made?
Robinson John Edward has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Robinson John Edward trade?
Robinson John Edward has filed SEC Form 4 disclosures for 1 company, including COGT.
When was Robinson John Edward's most recent SEC Form 4 filing?
Robinson John Edward's most recent SEC Form 4 filing on Tracefour is dated Dec 30, 2025.
What is Robinson John Edward's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Robinson John Edward is listed as Chief Scientific Officer.
What is Robinson John Edward's total buy and sell value in the current window?
Inside the rolling retention window, Robinson John Edward bought $0 and sold $3.5M based on SEC Form 4 filings.
What was Robinson John Edward's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 90,000 COGT shares on 2025-12-26, worth $3.5M, per SEC Form 4 filings.